Movano inc
MOVE 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分較低，若以價值投資為目標，已經有長期投資部位可能需陸續減碼
MOVE 近期報酬表現
-8.31%
Movano inc
2.92%
同產業平均
1.26%
S&P500
與 MOVE 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
NRXS | Neuraxis inc | - | 4 分 | 3 分 | 1 分 | 1 分 | |
MBOT | Microbot medical inc | 4 分 | 2 分 | 2 分 | 1 分 | 1 分 | |
MLSS | Milestone scientific inc. | 5 分 | 3 分 | 3 分 | 1 分 | 1 分 | |
STAA | Staar surgical company | 3 分 | 5 分 | 3 分 | 2 分 | 1 分 | |
EKSO | Ekso bionics holdings inc | 4 分 | 1 分 | 2 分 | 1 分 | 1 分 |
- NRXS Neuraxis inc價值 -趨勢 4 分波段 3 分籌碼 1 分股利 1 分查看更多
MOVE 公司資訊
Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual's health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.